LSTA – lisata therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Lisata Therapeutics, Inc. (NASDAQ: LSTA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year' [Yahoo! Finance]
Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’
Lisata Therapeutics Inc (LSTA) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Cost ... [Yahoo! Finance]
Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Form 10-Q LISATA THERAPEUTICS, For: Sep 30
Form 8-K LISATA THERAPEUTICS, For: Nov 12
Form 4 LISATA THERAPEUTICS, For: Oct 01 Filed by: Buck Kristen K
Form 4 LISATA THERAPEUTICS, For: Oct 01 Filed by: Nisco James
Form 4 LISATA THERAPEUTICS, For: Oct 01 Filed by: Mazzo David J
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.